Praxis pauses vormatrigine study after trial misses primary endpoint

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. PANW
2. GTLB
3. MDB
4. DELL
5. GOOGL
6. SPY
7. MMED
8. CRDO
9. GOOG
10. NVDA

Go back to Praxis pauses vormatrigine study after trial misses primary endpoint
(NASDAQ: PRAX) Delayed: 355.27 +1.83 (0.52%)
Previous Close $353.44    52 Week High $ 
Open $358.42    52 Week Low $ 
Day High $365.71    P/E N/A 
Day Low $347.01    EPS $ 
Volume 138,066